AstraZeneca to develop vaccines for new Covid strains in 6-9 months as sales hit $27bn – business live

5406.jpg?width=1200&height=630&quality=8

Markets quiet ahead of US jobless claims data

9.44am GMT

During the press conference, AstraZeneca said it is making more than 100m doses of its Covid-19 vaccine every month, and will ramp this up to over 200m a month from April.

8.47am GMT

Here is Reuters’ take on the AstraZeneca results.

AstraZeneca sees growth picking up, even without COVID-19 vaccine https://t.co/nJqKM5VKGJ pic.twitter.com/eRqE6iIfQi

Continue reading…